Novo Nordisk India Pushes for Early Wegovy Launch Amid Rising Competition
Novo Nordisk’s Indian team is urging the Danish pharmaceutical company to expedite the launch of its weight-loss drug Wegovy to counter Eli Lilly’s upcoming rival product,...
Etiket: Novo Nordisk
Medicaid Dominates U.S. Coverage for Novo Nordisk and Eli Lilly Weight-Loss Drugs
Government Programs Drive Access to GLP-1 Drugs State Medicaid programs and federal employee health plans are the leading sources of coverage for popular new weight-loss drugs,...
Novo Nordisk Raises Alarm Over Deaths Linked to Compounded Versions of Weight-Loss Drug Wegovy
Novo Nordisk recently acknowledged reports indicating that 10 people have died and over 100 have been hospitalized after using compounded versions of its popular weight-loss and...